Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,189,506
- Value
- $88.6M
- % of portfolio
- 1.9%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,189,506 | $88.6M | 1.9% | +1,164,129+4,587.3% | Added | Holders |
| Q1 2026 | 25,377 | $1.88M | <0.1% | +1,266+5.3% | Added | Holders |
| Q4 2025 | 24,111 | $1.84M | <0.1% | +3,755+18.4% | Added | Holders |
| Q3 2025 | 20,356 | $1.06M | <0.1% | +9,956+95.7% | Added | Holders |
| Q2 2025 | 10,400 | $449.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,400 | $359.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,400 | $285.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,400 | $264.8K | <0.1% | −2,400−18.8% | Reduced | Holders |
| Q2 2024 | 12,800 | $324.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 12,800 | $395.8K | <0.1% | −20,500−61.6% | Reduced | Holders |
| Q4 2023 | 33,300 | $1.34M | <0.1% | −45,400−57.7% | Reduced | Holders |
| Q3 2023 | 78,700 | $2.08M | <0.1% | −18,200−18.8% | Reduced | Holders |
| Q2 2023 | 96,900 | $1.67M | <0.1% | +14,300+17.3% | Added | Holders |
| Q1 2023 | 82,600 | $1.37M | <0.1% | +82,600 | New | Holders |